IP Library Granted Patent US 8,616,429
Granted Patent B2
US 8,616,429 · App. 13/676,461 · Granted Dec 31, 2013

Structure containing wound treatment material

Inventor: Frank J. Viola (Sandy Hook, CT)
Assignee: Covidien LP
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 8,616,429
App. No.
13/676,461
Granted
Dec 31, 2013
Kind
B2
Abstract

An anvil assembly for a circular stapling apparatus, is disclosed. The anvil assembly includes an anvil head configured to support an anvil plate thereon; a shaft extending from the anvil head and configured to selectively engage a connection member of the circular stapling apparatus; an anvil plate operatively connected to the anvil head, the anvil plate defining a plurality of staple forming pockets therein; and a wound treatment material disposed in each staple forming pocket of the anvil plate. The wound treatment material is at least one of an adhesive, a sealant, a hemostat and a medicament.

Claims (31)

1. A surgical stapling apparatus comprising:

a tubular body portion having a connection member;

a staple cartridge assembly operably supported on the tubular body portion, the staple cartridge assembly having a plurality of staple retaining slots and a surgical staple in each of the staple retaining slots;

an anvil head configured to support an anvil plate thereon, the anvil plate defining a plurality of staple forming pockets in registration with the staple retaining slots;

a shaft extending from the anvil head and configured to selectively engage the connection member of the tubular body portion; and

a wound treatment material disposed within each of the plurality of staple forming pockets of the anvil plate, wherein the wound treatment material is at least one of an adhesive, a sealant, a hemostat and a medicament, wherein the wound treatment material is contained in a capsule, wherein each capsule is configured for retention within the staple forming pockets.

2. The surgical stapling apparatus according to claim 1 , wherein the adhesive includes at least one of an adhesive which cures upon tissue contact, an adhesive which cures upon exposure to ultraviolet (UV) light, and an adhesive which is pressure sensitive.

3. The surgical stapling apparatus according to claim 1 , wherein the adhesive includes at least one of a protein derived, aldehyde-based adhesive material, and a cyanoacrylate-based material.

4. The surgical stapling apparatus according to claim 1 , wherein the sealant material includes at least one of a fibrin sealant material, a collagen-based and synthetic polymer-based tissue sealant material, and synthetic polyethylene glycol-based, hydrogel sealant material.

5. The surgical stapling apparatus according to claim 1 , wherein the hemostat material includes at least one of a fibrin-based material, a collagen-based material, an oxidized regenerated cellulose-based material, a gelatin-based material, and a fibrinogen-thrombin material.

6. The surgical stapling apparatus according to claim 1 , wherein the medicament includes at least one of drugs, enzymes, growth factors, peptides, proteins, dyes, and diagnostic agents.

7. The surgical stapling apparatus according to claim 1 , wherein the staple forming pockets are arranged in a pair of spaced apart concentric annular rings.

8. The surgical stapling apparatus according to claim 1 , wherein the staple forming pockets are in registration with respective staple retaining slots formed in a staple cartridge assembly of the surgical stapling apparatus.

9. A method of preparing a surgical stapling apparatus for use or providing a surgical stapling apparatus for joining a pair of opposed tissues, the method comprising the steps of:

providing a surgical stapling apparatus, including:

a tubular body portion having a connection member;

a staple cartridge assembly operably supported on the tubular body portion, the staple cartridge assembly having a plurality of staple retaining slots and a surgical staple in each of the staple retaining slots;

an anvil head configured to support an anvil plate thereon, the anvil plate defining a plurality of staple forming pockets in registration with the staple retaining slots; and

a shaft extending from the anvil head and configured to selectively engage the connection member of the tubular body portion;

disposing a wound treatment material within each of the plurality of staple forming pockets of the anvil plate, wherein the wound treatment material is at least one of an adhesive, a sealant, a hemostat and a medicament; and

placing the wound treatment material in a capsule prior to the step of disposing the wound treatment material within each of the plurality of staple forming pockets.

10. The method according to claim 9 , further comprising the step of placing a liner at least partially over the plurality of staple forming pockets after the step of disposing the wound treatment material within each of the plurality of staple forming pockets.

11. The method according to claim 10 , wherein the liner is fabricated from a bio-absorbable material.

12. The method according to claim 10 , wherein the liner is fabricated from a fluid impermeable material which is ruptured by staples of the surgical stapling apparatus.

13. The method according to claim 10 , wherein at least a portion of the liner remains in a patient's body after use of the surgical stapling apparatus.

14. The method according to claim 10 , wherein the adhesive includes at least one of a protein derived, aldehyde-based adhesive material, and a cyanoacrylate-based material.

15. The method according to claim 10 , wherein the sealant material includes at least one of a fibrin sealant material, a collagen-based and synthetic polymer-based tissue sealant material, and synthetic polyethylene glycol-based, hydrogel sealant material.

16. The method according to claim 10 , wherein the hemostat material includes at least one of a fibrin-based material, a collagen-based material, an oxidized regenerated cellulose-based material, a gelatin-based material, and a fibrinogen-thrombin material.

17. The method according to claim 10 , wherein the medicament includes at least one of drugs, enzymes, growth factors, peptides, proteins, dyes, and diagnostic agents.

18. The method according to claim 10 , further comprising the step of disposing a wound treatment material in within each of the plurality of staple retaining slots, wherein the wound treatment material is at least one of an adhesive, a sealant, a hemostat and a medicament.

19. The method according to claim 18 , further comprising the step of placing a liner over at least some of the plurality of staple retaining slots.

Assignments (2)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Nov 14, 2012
From: VIOLA, FRANK J.
To: TYCO HEALTHCARE GROUP LP
Reel/Frame 029294/0912 →
CHANGE OF NAME Recorded Nov 14, 2012
From: TYCO HEALTHCARE GROUP LP
To: COVIDIEN LP
Reel/Frame 029295/0115 →
Continuity (6)
Continuation 13285086 · Oct 31, 2011
Division 12715715 · Mar 2, 2010
Continuation 12259658 · Oct 28, 2008
Continuation 11048353 · Feb 1, 2005
Provisional Application 60620067 · Oct 18, 2004
Related Publication 20130068819A1 · Mar 21, 2013